What Can Pharma Do for Patients Post IRA?

Article

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform.

Kevin Hagan, president and CEO of the PAN Foundation, discusses how pharma can help Medicare patients post-IRA reform. Hagan notes there is a continuing need to have copay assistance because Medicare patients still face a $2K out of pocket cost, which is still a challenge for many of them.

Visit the PAN Foundation's "Everything You Need to Know About Medicare Reforms" for patients, providers and industry.

Related Videos
Related Content